KR102718536B1 - 2-(5-메톡시이소크로만-1-일)-4,5-디하이드로-1h-이미다졸 및 이의 하이드로젠설페이트 염의 제조방법 - Google Patents

2-(5-메톡시이소크로만-1-일)-4,5-디하이드로-1h-이미다졸 및 이의 하이드로젠설페이트 염의 제조방법 Download PDF

Info

Publication number
KR102718536B1
KR102718536B1 KR1020207019100A KR20207019100A KR102718536B1 KR 102718536 B1 KR102718536 B1 KR 102718536B1 KR 1020207019100 A KR1020207019100 A KR 1020207019100A KR 20207019100 A KR20207019100 A KR 20207019100A KR 102718536 B1 KR102718536 B1 KR 102718536B1
Authority
KR
South Korea
Prior art keywords
methoxyisochroman
chemical formula
formula
ethyl
carboxylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020207019100A
Other languages
English (en)
Korean (ko)
Other versions
KR20200095519A (ko
Inventor
일포 라이티넨
미코 레스키넨
미코 매켈래
Original Assignee
오리온 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오리온 코포레이션 filed Critical 오리온 코포레이션
Publication of KR20200095519A publication Critical patent/KR20200095519A/ko
Application granted granted Critical
Publication of KR102718536B1 publication Critical patent/KR102718536B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Epoxy Resins (AREA)
  • Detergent Compositions (AREA)
KR1020207019100A 2017-12-01 2018-11-30 2-(5-메톡시이소크로만-1-일)-4,5-디하이드로-1h-이미다졸 및 이의 하이드로젠설페이트 염의 제조방법 Active KR102718536B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20176085 2017-12-01
FI20176085 2017-12-01
PCT/FI2018/050864 WO2019106238A1 (en) 2017-12-01 2018-11-30 Process for the preparation of 2-(5-methoxyisochroman-1 -yl)-4,5-dihydro-1 h-imidazole and the hydrogensulfate salt thereof

Publications (2)

Publication Number Publication Date
KR20200095519A KR20200095519A (ko) 2020-08-10
KR102718536B1 true KR102718536B1 (ko) 2024-10-21

Family

ID=64746580

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207019100A Active KR102718536B1 (ko) 2017-12-01 2018-11-30 2-(5-메톡시이소크로만-1-일)-4,5-디하이드로-1h-이미다졸 및 이의 하이드로젠설페이트 염의 제조방법

Country Status (19)

Country Link
US (1) US11352346B2 (enExample)
EP (1) EP3717476B1 (enExample)
JP (1) JP7339946B2 (enExample)
KR (1) KR102718536B1 (enExample)
CN (1) CN111630049B (enExample)
AU (1) AU2018376872B2 (enExample)
BR (1) BR112020010617A2 (enExample)
CA (1) CA3083734A1 (enExample)
DK (1) DK3717476T3 (enExample)
ES (1) ES2927193T3 (enExample)
HR (1) HRP20221247T1 (enExample)
HU (1) HUE059849T2 (enExample)
IL (1) IL274931B2 (enExample)
LT (1) LT3717476T (enExample)
PL (1) PL3717476T3 (enExample)
PT (1) PT3717476T (enExample)
SI (1) SI3717476T1 (enExample)
WO (1) WO2019106238A1 (enExample)
ZA (1) ZA202003981B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112020003658T5 (de) 2019-07-31 2022-05-19 Hyundai Motor Company Sdn-basiertes eindringungsverhinderungsverfahren für ein fahrzeuginternesnetz und system, das dieses verfahren verwendet
KR20230159515A (ko) * 2021-03-19 2023-11-21 오리온 코포레이션 타시피미딘 제형 및 이의 용도
JP2025502480A (ja) * 2022-01-24 2025-01-24 オリオン コーポレーション イソクロマン－イミダゾール構造のアルファ－２ａアドレナリン受容体アゴニストの新規な硫酸塩形
WO2023148431A1 (en) 2022-02-04 2023-08-10 Orion Corporation Novel salt forms of isochroman-imidazole structured alpha-2a adrenoceptor agonist
JP2025531623A (ja) 2022-09-28 2025-09-22 オリオン コーポレーション タシピミジンおよびｃｙｐ２ｄ６阻害薬の併用療法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410562B1 (en) * 1998-12-18 2002-06-25 Eli Lilly And Company Hypoglycemic imidazoline compounds
AR090557A1 (es) * 2012-04-02 2014-11-19 Orion Corp DERIVADOS IMIDAZOLICOS AGONISTAS ADRENERGICOS a2

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
The Journal of Organic Chemistry, 2013, 제78권, 페이지 7356-7361

Also Published As

Publication number Publication date
US11352346B2 (en) 2022-06-07
HUE059849T2 (hu) 2023-01-28
US20200308152A1 (en) 2020-10-01
JP7339946B2 (ja) 2023-09-06
RU2020121597A3 (enExample) 2022-01-04
EP3717476B1 (en) 2022-08-03
LT3717476T (lt) 2022-09-26
AU2018376872B2 (en) 2023-12-07
CN111630049A (zh) 2020-09-04
IL274931A (en) 2020-07-30
ES2927193T3 (es) 2022-11-03
HRP20221247T1 (hr) 2022-12-09
EP3717476A1 (en) 2020-10-07
BR112020010617A2 (pt) 2020-11-10
RU2020121597A (ru) 2022-01-04
PT3717476T (pt) 2022-08-23
SI3717476T1 (sl) 2022-10-28
IL274931B2 (en) 2023-11-01
WO2019106238A1 (en) 2019-06-06
JP2021504418A (ja) 2021-02-15
CA3083734A1 (en) 2019-06-06
AU2018376872A1 (en) 2020-07-16
PL3717476T3 (pl) 2022-11-21
IL274931B1 (en) 2023-07-01
KR20200095519A (ko) 2020-08-10
CN111630049B (zh) 2023-06-20
DK3717476T3 (da) 2022-09-05
ZA202003981B (en) 2021-07-28

Similar Documents

Publication Publication Date Title
JP5632279B2 (ja) 塩酸イバブラジンの調製方法及びポリモルフ
KR20200095519A (ko) 2-(5-메톡시이소크로만-1-일)-4,5-디하이드로-1h-이미다졸 및 이의 하이드로젠설페이트 염의 제조방법
CN101547892B (zh) 制备(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的方法和其中间体
TWI809018B (zh) 用於製備喹啉衍生物之方法
KR20130129180A (ko) 아미노벤조일벤조푸란 유도체의 제조 방법
US20140039194A1 (en) Process and intermediates for preparing integrase inhibitors
WO2019036441A1 (en) PROCESSES FOR PREPARING NIRAPARIB AND INTERMEDIATES THEREOF
WO2017189339A1 (en) Process for the preparation of n-[(5-pyrimidinyl)methyl]-2-pyridinamines
WO2018187717A1 (en) Continuous flow synthesis of ibuprofen
US20200002291A1 (en) Benzimidazole Compound and Preparation Method Thereof
CN114727977A (zh) 化合物和化合物s1p1调节剂的制备方法
TWI724031B (zh) 製備1-(4-甲烷磺醯基-2-三氟甲基-苄基)-2-甲基-1h-吡咯并[2,3-b]吡啶-3-基-乙酸之方法
WO2012127483A1 (en) Processes for the preparation of intermediates of n-[2-(7-methoxy-1-naphthyl) ethyl] acetamide
CN108947800B (zh) 一种(1s)-4，5-二甲氧基-1-(羰基氨基甲基)苯并环丁烷的合成方法
RU2791469C2 (ru) Способ получения 2-(5-метоксиизохроман-1-ил)-4,5-дигидро-1h-имидазола и его гидросульфата
CN118139848A (zh) 用于制备双间苯二酚基三嗪的方法
SK9892003A3 (en) An improved process for preparing pure ondansetron hydrochloride dihydrate
KR20110074875A (ko) 치환된 페닐알라닌의 제조 방법
JP6660393B2 (ja) ４−シアノピペリジン塩酸塩を調製する方法
WO2014049609A2 (en) Novel salts of vilazodone
CA2558817A1 (en) Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
HK40075726A (en) Compounds and methods of preparing compounds s1p1 modulators
HK1230509A1 (en) Clomiphene synthesis using a single solvent
HK1097845B (zh) 制备2-(乙氧基甲基)-托烷衍生物的方法
HK1097845A1 (zh) 制备2-(乙氧基甲基)-托烷衍生物的方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20200701

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20211111

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20240108

Patent event code: PE09021S01D

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20241014

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20241015

End annual number: 3

Start annual number: 1

PG1601 Publication of registration